Ophthalmology · Scleritis

Mapping the Disease: Subtypes and Location

At a Glance

The location and subtype of idiopathic scleritis help determine its symptoms, testing, and outlook. Diffuse and nodular disease often has a more favorable course, while posterior and necrotizing forms carry higher risks of vision loss, retinal fluid, optic nerve swelling, or scleral thinning.

Scleritis is not a one-size-fits-all condition. Even when the cause is “idiopathic” (unknown), the way the inflammation behaves depends heavily on where it is located and which specific subtype is active. Doctors categorize scleritis based on its location—anterior (the front of the eye) or posterior (the back of the eye)—and how the tissue reacts to the inflammation ^[1]^[2].

Anterior Scleritis: The Visible Subtypes

Anterior scleritis is the most common form and is visible to the naked eye. It is divided into three main subtypes based on how the inflammation looks during a clinical exam.

Diffuse Anterior Scleritis: This is the most common form ^[1]. The redness is spread widely across the white of the eye. While uncomfortable, it typically has a more favorable long-term outlook and is generally less likely to cause permanent structural damage to the eye compared to other forms ^[3].
Nodular Anterior Scleritis: In this form, the inflammation is concentrated into one or more firm, painful bumps (nodules) on the surface of the eye ^[4]. While the overall prognosis is usually favorable, nodular scleritis is known for being stubborn—it can recur frequently, with some studies showing recurrence in up to 74% of cases ^[4]^[5]. Nodular disease does not necessarily progress into necrotizing disease.
Necrotizing Anterior Scleritis: This is the most severe and dangerous form of anterior scleritis ^[2]. It is characterized by severe tissue damage and necrosis (tissue death). Necrotizing disease can occur with intense, painful inflammation, or it can occur silently with very little visible inflammation (a condition known as scleromalacia perforans, which is often associated with advanced rheumatoid arthritis) ^[2]^[6]. This can lead to extreme thinning of the eye wall, sometimes allowing the dark inner layers of the eye (the uvea) to show through or, in rare cases, leading to a perforation (a hole in the eye wall) ^[7]^[8].

Posterior Scleritis: The Hidden Inflammation

Posterior scleritis occurs behind the part of the eye you can see in the mirror. Because it is “hidden,” it is often harder to diagnose and may be mistaken for other conditions like a detached retina or a tumor ^[9]^[10].

Presentation: Patients with posterior scleritis often report blurred vision, a deep ache, and pain when moving their eyes ^[11]^[9].
Detection: Since a doctor cannot see the back of the sclera directly, they use imaging. A B-scan ultrasound is the most common tool. It can reveal a “T-sign,” which occurs when fluid builds up behind the eye and around the optic nerve, creating a T-shaped shadow on the scan ^[12]^[11]. (Note that a T-sign is helpful when present, but it is not present in every case).
Risks: Posterior scleritis can cause complications such as fluid buildup under the retina (exudative retinal detachment) or swelling of the optic nerve, both of which can significantly impact vision if not managed promptly ^[13]^[12].

Outlook and Prognosis

Your long-term outlook depends on which subtype you have, the severity of the inflammation, and how quickly it responds to treatment.

Subtype	General Outlook	Primary Risks
Diffuse	Generally favorable	Recurrence, mild discomfort ^[1]
Nodular	Favorable but stubborn	Frequent recurrences ^[4]
Posterior	Guarded to Favorable	Vision loss from retinal fluid or nerve swelling ^[14]^[15]
Necrotizing	Serious	Scleral thinning, perforation, and permanent vision loss ^[16]^[8]

While the diffuse and nodular forms generally have a lower risk of permanent vision loss, the necrotizing and posterior forms are considered high-risk. These subtypes are more likely to lead to secondary complications like cataracts (clouding of the lens) or glaucoma (increased eye pressure) ^[17]^[8]. Identifying your specific subtype early is an important step in protecting the integrity of your eye ^[18].

Common questions in this guide

What are the different types of idiopathic scleritis?

Scleritis is classified by location as anterior or posterior. Anterior scleritis may be diffuse, nodular, or necrotizing, while posterior scleritis affects the back of the eye. Knowing the subtype helps an eye specialist estimate the risk of recurrence, structural damage, and vision problems.

What symptoms can suggest posterior scleritis?

Posterior scleritis may cause blurred vision, a deep ache, and pain when moving the eyes. Because the inflammation is behind the visible part of the eye, it can be harder to recognize and may resemble retinal detachment or a tumor. Prompt eye evaluation is important when these symptoms occur.

How does an ultrasound help diagnose posterior scleritis?

A B-scan ultrasound can show fluid behind the eye and around the optic nerve. This may create a T-shaped shadow called a T-sign, which can support the diagnosis. A T-sign is helpful when present, but it does not appear in every case.

Can nodular scleritis come back?

Nodular scleritis generally has a favorable outlook but can be persistent and recur. Recurrence has been reported in up to 74% of cases. Regular follow-up helps an eye specialist identify renewed inflammation early.

Which types of scleritis pose the greatest threat to vision?

Necrotizing anterior scleritis is the most severe form and can cause extreme thinning or, rarely, a hole in the eye wall. Posterior scleritis can also threaten vision because fluid may collect under the retina or the optic nerve may swell. Both forms need prompt medical assessment.

What complications should be monitored with scleritis?

High-risk scleritis can lead to retinal fluid, optic nerve swelling, scleral thinning, and vision loss. Scleritis may also be associated with cataracts or glaucoma, which are clouding of the lens and increased pressure inside the eye. Ask your eye specialist which complications should be checked during follow-up.

Curated prompts to bring to your next appointment.

1.Based on my exam, which specific subtype of scleritis do I have: diffuse, nodular, or necrotizing?
2.If I have nodular scleritis, how do we monitor it to ensure we manage any recurrences effectively?
3.What did the B-scan ultrasound show regarding the thickness of the back of my eye and the presence of any 'T-sign'?
4.Are there any signs of 'melting' or thinning in my sclera that could put my eye's structure at risk?
5.Given my subtype, what is the specific risk to my long-term vision, and what complications (like glaucoma or cataracts) should we watch for?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (18)

1
[Scleritis and systemic diseases: What should know the internist?]
Bielefeld P, Saadoun D, Héron E, et al.
La Revue de medecine interne 2018; (39(9)):711-720 doi:10.1016/j.revmed.2018.02.001.
PMID: 29496270
2
[Diagnosis and treatment approach for necrotizing scleritis (NS): A clinical case].
Hernández-Camarena JC, Rodríguez-García A, Valdez-García J
Gaceta medica de Mexico 2015; (151(4)):525-8.
PMID: 26290030
3
Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging.
Kuroda Y, Uji A, Morooka S, et al.
The British journal of ophthalmology 2017; (101(4)):411-417 doi:10.1136/bjophthalmol-2016-308561.
PMID: 27388252
4
Clinical profile of patients with anterior nodular scleritis in India.
Patnaik G, Sudharshan S, George AE, et al.
Indian journal of ophthalmology 2020; (68(9)):1925-1928 doi:10.4103/ijo.IJO_2154_19.
PMID: 32823416
5
Clinical profile of patients with posterior scleritis: A report from Eastern India.
Kumar A, Ghose A, Biswas J, Majumder PD
Indian journal of ophthalmology 2018; (66(8)):1109-1112 doi:10.4103/ijo.IJO_121_18.
PMID: 30038152
6
Necrotizing Scleritis: A Review.
Dutta Majumder P, Agarwal S, Shah M, et al.
Ocular immunology and inflammation 2024; (32(7)):1405-1419 doi:10.1080/09273948.2023.2206898.
PMID: 37279404
7
Scleral Patch Graft With a Suture Reinforcement Technique in Surgical Management of Necrotizing Scleritis With Ectasia.
Wen JC, Lam J, Banitt MR
Cornea 2018; (37(7)):933-935 doi:10.1097/ICO.0000000000001598.
PMID: 29664747
8
Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.
Dutta Majumder P, Ghose A, Chidambaram M, et al.
Ocular immunology and inflammation 2018; (26(3)):412-416 doi:10.1080/09273948.2016.1223857.
PMID: 27762661
9
NODULAR POSTERIOR SCLERITIS: Clinico-Sonographic Characteristics and Proposed Diagnostic Criteria.
Agrawal R, Lavric A, Restori M, et al.
Retina (Philadelphia, Pa.) 2016; (36(2)):392-401 doi:10.1097/IAE.0000000000000699.
PMID: 26296144
10
Monocular posterior scleritis presenting as acute conjunctivitis: A case report.
Li YZ, Qin XH, Lu JM, Wang YP
World journal of clinical cases 2020; (8(20)):5030-5035 doi:10.12998/wjcc.v8.i20.5030.
PMID: 33195678
11
Clinical Features, Treatment, and Visual Outcomes of Posterior Scleritis from Tertiary Eye Care Center.
Tellioğlu A, Yargı Özkoçak B, Kemer Atik B, et al.
Ocular immunology and inflammation 2024; (32(7)):1323-1329 doi:10.1080/09273948.2023.2241556.
PMID: 37549312
12
The clinical features of posterior scleritis with serous retinal detachment: a retrospective clinical analysis.
Dong ZZ, Gan YF, Zhang YN, et al.
International journal of ophthalmology 2019; (12(7)):1151-1157 doi:10.18240/ijo.2019.07.16.
PMID: 31341807
13
Choroidal involvement in non-infectious posterior scleritis.
Vermeirsch S, Testi I, Pavesio C
Journal of ophthalmic inflammation and infection 2021; (11(1)):41 doi:10.1186/s12348-021-00269-9.
PMID: 34705127
14
Posterior Scleritis: Analysis of Epidemiology, Clinical Factors, and Risk of Recurrence in a Cohort of 114 Patients.
Lavric A, Gonzalez-Lopez JJ, Majumder PD, et al.
Ocular immunology and inflammation 2016; (24(1)):6-15 doi:10.3109/09273948.2015.1005240.
PMID: 26134101
15
Clinical characteristics and ocular complications of patients with scleritis in Japanese.
Tanaka R, Kaburaki T, Ohtomo K, et al.
Japanese journal of ophthalmology 2018; (62(4)):517-524 doi:10.1007/s10384-018-0600-y.
PMID: 29796754
16
Pattern of Scleritis in an Egyptian Cohort.
Abd El Latif E, Seleet MM, El Hennawi H, et al.
Ocular immunology and inflammation 2019; (27(6)):890-896 doi:10.1080/09273948.2018.1544372.
PMID: 30412434
17
Clinical profile, treatment, and visual outcome of scleritis: A single ophthalmologist experience.
Magesan K, Patnaik G, Majumder PD, Biswas J
Oman journal of ophthalmology 2022; (15(2)):153-158 doi:10.4103/ojo.ojo_168_21.
PMID: 35937739
18
Current Approach for the Diagnosis and Management of Noninfective Scleritis.
Dutta Majumder P, Agrawal R, McCluskey P, Biswas J
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; (10(2)):212-223 doi:10.1097/APO.0000000000000341.
PMID: 33290287

This page is for informational purposes only and does not constitute medical advice. An ophthalmologist should interpret your examination and imaging and discuss your individual risks from idiopathic scleritis.

Get notified when new evidence is published on Idiopathic scleritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents